William C. Denby

Filings by William C. Denby span 2 companies, the busiest being Santarus Inc and Adamis Pharmaceuticals Corp. In total, 141 filings cover trades dated from 26 January 2006 to 24 May 2019.

The open-market side counts 2 purchases for €19k alongside 113 sales for €3.8M. On balance, insiders were net sellers of €3.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 9 share grants and 15 option exercises. In 2019 alone, the filings show 1 purchase and no sales.

On 28 May 2019 came the latest disclosure, an open-market purchase for €8,941 in Adamis Pharmaceuticals Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.